Letter: The Addition of an Immunosuppressant in Patients With Unsatisfactory Response to Vedolizumab

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14541
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Letter: The Addition of an Immunosuppressant in Patients With Unsatisfactory Response to Vedolizumab-Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: Addition of Methotrexate Neither Restores Clinical Response Nor Improves the Pharmacokinetic Profile of Vedolizumab-Treated Patients

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Rapid Response to Vedolizumab Therapy in Biologic-Naïve Patients With Inflammatory Bowel Diseases

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

Letter: Can Addition of an Immunomodulator Really Reverse Antibody Formation and Loss of Response in Patients Treated With Adalimumab?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Letter: Can Addition of an Immunomodulator Really Reverse Antibody Formation and Loss of Response in Patients Treated With Adalimumab? Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Letter: Psoriasiform Eruption During Vedolizumab Therapy

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Response to the Letter

Angle Orthodontist
MedicineOrthodontics
2020English

Response to the Letter

Angle Orthodontist
MedicineOrthodontics
2020English

Letter: Vedolizumab Drug Concentrations in Neonates Following Intrauterine Exposure

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy